Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis.

Taherifard E, Bakhtiar M, Mahnoor M, Ahmed R, Cavalcante L, Zhang J, Saeed A.

Open source

DOI
10.1186/s12885-024-11926-2
Published
2024-02-12
Container
BMC Cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-024-11926-2,
  title = {Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis.},
  author = {Taherifard E and  Bakhtiar M and  Mahnoor M and  Ahmed R and  Cavalcante L and  Zhang J and  Saeed A.},
  year = {2024},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-024-11926-2},
  url = {https://doi.org/10.1186/s12885-024-11926-2}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
AU  - Taherifard E
AU  -  Bakhtiar M
AU  -  Mahnoor M
AU  -  Ahmed R
AU  -  Cavalcante L
AU  -  Zhang J
AU  -  Saeed A.
PY  - 2024
JO  - BMC Cancer
DO  - 10.1186/s12885-024-11926-2
UR  - https://doi.org/10.1186/s12885-024-11926-2
ER  - 

APA

E, T., M, B., M, M., R, A., L, C., J, Z., & A., S. (2024). Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis.. BMC Cancer. https://doi.org/10.1186/s12885-024-11926-2

Source records